首页> 外文会议>Falk Symposium >Immunology of primary biliary cirrhosis and primary sclerosing cholangitis
【24h】

Immunology of primary biliary cirrhosis and primary sclerosing cholangitis

机译:原发性胆汁肝硬化和原发性胆管炎的免疫学

获取原文
获取外文期刊封面目录资料

摘要

Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease of unknown aetiology characterized by high titre serum antimitochondrial autoantibodies (AMA), a striking female predominance, and an autoimmune-mediated destruction of the small and medium-size intrahepatic bile ducts . PBC is a peculiar, yet representative, organ-specific autoimmune disease. The presence of serum AMA and autoreactive T and B cells, in conjunction with the co-occurrence of other autoimmune diseases, implies an autoimmune pathogenesis for PBC. A complex genetic background is suggested by the incidence of the disease among first-degree relatives, the high concordance rate among twins3, and the proposed role for sex chromosome defects4. To summarize, PBC onset recognizes two necessary components: i.e. a permissive genetic background and an environmental trigger.
机译:原发性胆汁肝硬化(PBC)是一种未知病毒学的慢性胆汁淤积性肝病,其特征在于高滴度血清抗度粒子自身抗体(AMA),一种引人注目的女性优势,以及自身免疫介导的中小型肝内胆管的破坏。 PBC是一种奇特,但代表性的器官特异性自身免疫疾病。 与其他自身免疫疾病的共同发生,血清AMA和自动反应性T和B细胞的存在意味着PBC的自身免疫发病机制。 一系列复杂的遗传背景是由一级亲属,Twins3之间的高一致性率以及性染色体缺陷的拟议作用,提出了一种复杂的遗传背景。 总而言之,PBC发作识别两个必要的组分:即允许遗传背景和环境触发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号